KENDRA GOTTLIEB: Open Payments
NPI 1801342175 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 9 payments from 5 companies in 2025. Trend: 2023 $140 · 2024 $364 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $83 |
| Alnylam Pharmaceuticals Inc. | 2 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| United Therapeutics Corporation | 1 | $29 |
| Corcept Therapeutics | 1 | $24 |
Products named: Ozempic, ONPATTRO, Kerendia, Tyvaso, Korlym.
Industry payments across TX — which companies pay providers there.
